IP Library Granted Patent US 8,961,917
Granted Patent B2
US 8,961,917 · App. 13/106,637 · Granted Feb 24, 2015

Lanthanum carbonate hydroxide, lanthanum oxycarbonate and methods of their manufacture and use

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,961,917
App. No.
13/106,637
Granted
Feb 24, 2015
Kind
B2
Abstract

The present invention is a method of producing a lanthanum carbonate hydroxide or lanthanum oxycarbonate which has improved properties. The method involves the use of a water soluble lanthanum and a water soluble non-alkali metal carbonate or bicarbonate. The resulting material can be used as a phosphate binder individually or for treating patients with hyperphosphatemia.

Claims (7)

1. A method of producing a lanthanum carbonate compound comprising reacting a soluble salt of lanthanum chloride with ammonium carbonate in a solvent at a reaction temperature from between about 75 degrees C. to about 90 degrees C., at a pH of from about 6.0 to 7.5, and precipitating the reaction product, wherein the reaction product is lanthanum carbonate hydroxide which includes about 0.5% by weight or less of sodium.

2. The method of claim 1 wherein the amount of lanthanum chloride relative to the amount of ammonium carbonate in the reaction ranges from between about 1:0.8 and about 1:4.

3. The method of claim 1 wherein the lanthanum carbonate hydroxide produced has a pattern matching ICDD file 26-815.

4. The method of claim 1 further comprising calcining the reaction product at a temperature between about 400 and about 700 degrees C. for at least two hours to produce lanthanum dioxycarbonate comprising one or more polymorphs of formulae La 2 O 2 CO 3 and La 2 CO 5 and which includes about 0.75% by weight or less of sodium.

5. The method of claim 4 wherein the calcination temperature is about 550 degrees C.

6. The method of claim 4 wherein the resulting lanthanum dioxycarbonate comprises no more than about 5% by weight of the polymorph of formula La 2 CO 5 .

7. The method of claim 4 wherein the resulting lanthanum dioxycarbonate comprises no more than about 1% by weight of the polymorph of formula La 2 CO 5 .

Assignments (5)
QUITCLAIM PATENT ASSIGNMENT WITH AN EFFECTIVE DATE OF 9/20/2018 Recorded Jun 29, 2021
From: SPECTRUM PHARMACEUTICALS, INC.
To: UNICYCIVE THERAPEUTICS, INC.
Reel/Frame 056713/0060 →
RELEASE OF SECURITY INTEREST Recorded Jan 17, 2014
From: BANK OF AMERICA, N.A.
To: SPECTRUM PHARMACEUTICALS, INC.
Reel/Frame 031995/0892 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 5, 2013
From: SINGH, RAMSHARAN
To: SPECTRUM PHARMACEUTICALS, INC.
Reel/Frame 030165/0481 →
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Sep 20, 2012
From: SPECTRUM PHARMACEUTICALS, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 029017/0877 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 15, 2011
From: GORE, ASHOK YESHWANT; DIXIT, MILIND; MAHALINGAM, RAVICHANDRAN; SCHAUER, EDWARD A.; STEWART, MATTHEW; TANDALE, RAJENDRA
To: SPECTRUM PHARMACEUTICALS, INC.
Reel/Frame 026916/0409 →